Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation. (Q43744458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

main subject

coronary artery disease

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Davide Capodanno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Piera Capranzano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

13

Dominick J Angiolillo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Masafumi Ueno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Antonio Tello-Montoliu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Salvatore D Tomasello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Kodlipet Dharmashankar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Andrew Darlington

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Bhaloo Desai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Fabiana Rollini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Luis A Guzman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Theodore A Bass

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Thrombolysis

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

155-164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11239-012-0846-z

18 February 2020

exact match

0 references

cites work

Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Diabetes and antiplatelet therapy in acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Cangrelor: a review on its mechanism of action and clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Platelet inhibition with cangrelor in patients undergoing PCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Intravenous platelet blockade with cangrelor during PCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

New directions in antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Antiplatelet effects of aspirin vary with level of P2Y₁₂ receptor blockade supplied by either ticagrelor or prasugrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

The platelet P2 receptors in arterial thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

A cell-based model of thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-012-0846-Z

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study

21 January 2018

1 reference

12 December 2020

The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity

1 reference

12 December 2020

Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease

1 reference

12 December 2020

Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes

1 reference

12 December 2020

Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk

1 reference

12 December 2020

Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.

1 reference

12 December 2020

Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial

1 reference

12 December 2020

Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials

1 reference

12 December 2020

Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment

1 reference

12 December 2020

10.1007/S11239-012-0846-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23184484%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference